Department of Surgery, Amsterdam UMC, location AMC, Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, The Netherlands.
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam Public Health, University of Amsterdam, PO Box 22660, Amsterdam, 1100 DD, The Netherlands.
Trials. 2021 Apr 21;22(1):297. doi: 10.1186/s13063-021-05202-y.
Surgical site infections (SSI) are frequent complications after elective abdominal surgery. We designed the Enhanced PeriOperative Care and Health Protection programme (EPOCH) care bundle, comprising of intraoperative high fractional inspired oxygen; intraoperative goal-directed fluid therapy; active preoperative, intraoperative and postoperative warming; glucose control and treatment of hyperglycaemia (> 10 mmol L) in diabetics as well as non-diabetics; and wound irrigation before closure using an aqueous antiseptic. We hypothesise that EPOCH added to standard care reduces the incidence of SSI compared to standard care alone for elective abdominal surgery.
This trial is designed as an open label, pragmatic randomised controlled parallel-group multicentre superiority trial. The primary endpoint is the incidence of SSI, defined by the Centers for Disease Control and prevention, within 30 days after surgery. The incidence of SSI is assessed using the Dutch national complication register and medical chart review. Secondary endpoints include the SSI incidence within 90 days, incidence of anastomotic leakage at 30 and 90 days, the incidence of incisional hernia within 1 year, mortality within 1 year and 5 years, quality of life, health and disability, and cost-effectiveness. Primarily, an intention-to-treat analysis will be performed to estimate the relative risk using a log binomial model. If not feasible, a logistic regression will be used to estimate the odds ratio. A per-protocol analysis will also be performed. Furthermore, the attributive effect of the distinct interventions will be explored.
The results of the EPOCH trial will determine if the EPOCH bundle is effective to prevent SSI incidence for patients undergoing elective abdominal surgery. Details of the statistical analysis are described in this Statistical Analysis Plan (SAP).
Registration number: Dutch Trial Register Trial NL5572 . Registered on March 3, 2016. SAP version: V1.0, January 8, 2020. This SAP has been written based on study protocol V10.
手术部位感染(SSI)是择期腹部手术后常见的并发症。我们设计了增强围手术期护理和健康保护计划(EPOCH)护理包,包括术中高分数吸氧;术中目标导向液体治疗;主动术前、术中和术后保暖;糖尿病和非糖尿病患者的血糖控制和高血糖(>10mmol/L)治疗;以及在关闭切口前使用水性防腐剂冲洗伤口。我们假设 EPOCH 联合标准护理比单独使用标准护理可降低择期腹部手术的 SSI 发生率。
本试验设计为开放性、实用随机对照平行组多中心优效性试验。主要终点是术后 30 天内由疾病控制和预防中心定义的 SSI 发生率。SSI 的发生率通过荷兰国家并发症登记处和病历回顾进行评估。次要终点包括 90 天内 SSI 的发生率、30 天和 90 天吻合口漏的发生率、1 年内切口疝的发生率、1 年内和 5 年内的死亡率、生活质量、健康和残疾情况以及成本效益。主要采用意向治疗分析,使用对数二项式模型估计相对风险。如果不可行,则使用逻辑回归估计优势比。还将进行方案分析。此外,还将探讨不同干预措施的归因效果。
EPOCH 试验的结果将确定 EPOCH 包是否有效预防接受择期腹部手术的患者发生 SSI。统计分析的详细信息在本统计分析计划(SAP)中描述。
注册号:荷兰试验注册试验 NL5572。于 2016 年 3 月 3 日注册。SAP 版本:V1.0,2020 年 1 月 8 日。本 SAP 是根据研究方案 V10 编写的。